Why Senseonics Stock Skyrocketed 80% Today
The specialist in glucose monitoring is helping people with diabetes manage their health.
The specialist in glucose monitoring is helping people with diabetes manage their health.
An overall market sell-off stemming from increased coronavirus worries weighed on all three healthcare stocks.
The company presented data on its continuous glucose monitoring system, but investors may be more excited about being joined by George Soros.
Investors reacted enthusiastically to a positive coverage decision for the company's Eversense CGM device.
It wasn’t a good quarter for the diabetes-device company.
The continuous glucose monitoring systems maker's main problem: declining sales.
SENS earnings call for the period ending June 30, 2019.
SENS earnings call for the period ending June 30, 2019.
Dilution is on the way, causing at least temporary pain for shareholders.
SENS earnings call for the period ending March 31, 2019.